These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32598733)

  • 1. [Brain MRI-findings in Ph - negative myeloproliferative disorders].
    Tanashyan MM; Melikyan AL; Kuznetsova PI; Raskurazhev AA; Shabalina AA; Konovalov RN
    Ter Arkh; 2019 Jul; 91(7):29-34. PubMed ID: 32598733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Characteristics of Cerebrovascular Pathology with Patients Suffering from Ph-Negative Myeloproliferative Disease.
    Tanashyan MM; Kuznetsova PI; Shabalina AA; Raskurazhev AA; Lagoda OV; Subortseva IN; Melikyan AL
    Cerebrovasc Dis Extra; 2016; 6(3):66-70. PubMed ID: 27598581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covert Brain Infarcts in Patients with Philadelphia Chromosome-Negative Myeloproliferative Disorders.
    Kuznetsova PI; Raskurazhev AA; Konovalov RN; Krotenkova MV; Chechetkin AO; Lagoda OV; Melikhyan AL; Tanashyan MM
    J Clin Med; 2021 Dec; 11(1):. PubMed ID: 35011753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders. A retrospective analysis of 260 patients.
    Wehmeier A; Daum I; Jamin H; Schneider W
    Ann Hematol; 1991 Aug; 63(2):101-6. PubMed ID: 1912029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
    Iványi JL; Marton E; Plander M
    Orv Hetil; 2011 Nov; 152(45):1795-803. PubMed ID: 22011365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and brain MRI findings in myeloproliferative neoplasms.
    Nagai K; Shimoyama T; Yamaguchi H; Sakamoto Y; Suda S; Wakita S; Nishiyama Y; Inokuchi K; Kimura K
    J Neurol Sci; 2020 Sep; 416():116990. PubMed ID: 32593885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-induced thrombocytopenia in patients with Philadelphia-negative myeloproliferative disorders and unusual splanchnic or cerebral vein thrombosis.
    Randi ML; Tezza F; Scapin M; Duner E; Scarparo P; Scandellari R; Fabris F
    Acta Haematol; 2010; 123(3):140-5. PubMed ID: 20134155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombosis in the Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.
    Sankar K; Stein BL; Rampal RK
    Cancer Treat Res; 2019; 179():159-178. PubMed ID: 31317487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and treatment of BCR/ABL-negative myeloproliferative diseases--principles and rationale of CZEMP recommendations].
    Schwarz J; Penka M; Campr V; Pospísilová D; Kren L; Nováková L; Bodzásová C; Brychtová Y; Cerná O; Dulícek P; Joniásová A; Kissová J; Korístek Z; Schützová M; Vonke I; Walterová L
    Vnitr Lek; 2011 Feb; 57(2):189-213. PubMed ID: 21416861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombosis in myeloproliferative neoplasms].
    Asakura H
    Rinsho Ketsueki; 2018; 59(8):1034-1041. PubMed ID: 30185703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effectiveness of anagrelide treatment in patients with Ph negative myeloproliferative diseases: influence on the incidence of thrombosis in the data from the Registry of patients with essential thrombocythemia and thrombocythemia associated with other myeloproliferative diseases treated with Thromboreductin® to the end of 2012].
    Penka M; Schwarz J; Ovesná P; Cervinek L; Dulíček P; Pospíšilová D; Kissová J; Pavlík T;
    Vnitr Lek; 2013 Jun; 59(6):516-31. PubMed ID: 23808749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythromelalgia--a thrombotic complication in chronic myeloproliferative disorders.
    Tarach JS; Nowicka-Tarach BM; Matuszek B; Nowakowski A
    Med Sci Monit; 2000; 6(1):204-8. PubMed ID: 11208311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloproliferative disorders (MPD): myelofibrosis, myelosclerosis, extramedullary hematopoiesis, undifferentiated MPD, and hemorrhagic thrombocythemia.
    Laszlo J
    Semin Hematol; 1975 Oct; 12(4):409-32. PubMed ID: 1105793
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiac involvement in patients with myeloproliferative disorders.
    Reisner SA; Rinkevich D; Markiewicz W; Tatarsky I; Brenner B
    Am J Med; 1992 Nov; 93(5):498-504. PubMed ID: 1442851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin for the control of platelet activation and prevention of thrombosis in essential thrombocythemia and polycythemia vera: current insights and rationale for future studies.
    Landolfi R; Di Gennaro L; Novarese L; Patrono C
    Semin Thromb Hemost; 2006 Apr; 32(3):251-9. PubMed ID: 16673279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Budd-Chiari syndrome and thrombosis of other abdominal vessels in the chronic myeloproliferative diseases.
    Anger BR; Seifried E; Scheppach J; Heimpel H
    Klin Wochenschr; 1989 Aug; 67(16):818-25. PubMed ID: 2796252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Manifestations and Risk Factors for Complications of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.
    Duangnapasatit B; Rattarittamrong E; Rattanathammethee T; Hantrakool S; Chai-Adisaksopha C; Tantiworawit A; Norasetthada L
    Asian Pac J Cancer Prev; 2015; 16(12):5013-8. PubMed ID: 26163633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary hypertension associated with myeloproliferative disorders: a retrospective study of ten cases.
    Guilpain P; Montani D; Damaj G; Achouh L; Lefrère F; Le Pavec J; Marfaing-Koka A; Dartevelle P; Simonneau G; Humbert M; Hermine O
    Respiration; 2008; 76(3):295-302. PubMed ID: 18160817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombosis in myeloproliferative disorders: prevalence, prognostic factors, and the role of leukocytes and JAK2V617F.
    Tefferi A; Elliott M
    Semin Thromb Hemost; 2007 Jun; 33(4):313-20. PubMed ID: 17525888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
    Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
    Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.